Zhongshan Latterson Biotechnology Co., Ltd.

Other Hot-Sale Products (Raw Powder)

» Other Hot-Sale Products (Raw Powder)

Masitinib Powder CAS: 790299-79-5 / Treatment of multiple myeloma, gastrointesti

CATEGORY AND TAGS:
Other Hot-Sale Products (Raw Powder)
Model Number : 790299-79-5
Certification : GMP, SGS , ISO 9001:2008 , KOSHER
Place of Origin : China
MOQ : 1g
Price : Negotiable ( Discounts For Big Order )
Payment Terms : Western Union, MoneyGram, Bank Transfer, Bitcoin
Supply Ability : 2 KG/Month
Delivery Time : Within 7 Working Days
Packaging Details : Stealth And Discreet Packaging
Product Name : Masitinib
Other Name : AB1010
CAS : 790299-79-5
MF : C28H30N6OS
MW : 498.64
Appearance : White Powder
enquiry
  • Specifications

Masitinib Powder CAS: 790299-79-5 / Treatment of multiple myeloma, gastrointesti

Superiority
Zhongshan Latterson Biotechnology Co., Ltd., is a comprehensive pharmaceutical enterprise, which specialized in bio-pharmaceutical technology over 7 years. The company is located in Zhongshan City, Guangdong Province , China.
Our factory covers an area of 33500 square meters, with clean environment and nice layout. There are several large or medium workshops and QA and research center with advanced equipment. At present, our main products are Anabolic Steroid series, Peptide series, Local Anesthetic series. Our products reach the advanced standard of domestic market, many of which reach the international standard, certificates contain: KOSHER , ISO 9001:2008 , GMP , SGS.

Product Name: Masitinib
Synonyms: MASITINIB;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide;4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide;Ab 1010;Ab1010;Ab-1010;Mastinib;Masitinib(AB1010)
CAS: 790299-79-5
MF: C28H30N6OS
MW: 498.64
Product Categories: Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Anti-cancer&immunity;Inhibitors
Mol File: 790299-79-5.mol
Masitinib (AB1010) Structure
Masitinib (AB1010) Chemical Properties
Melting point 90-95°C
storage temp. Refrigerator
Masitinib (AB1010) Usage And Synthesis
Pharmacological effects Masitinib, also known as methotrexate masitinib, is studied and developed by the AB Science, a platelet-derived growth factor alpha/beta receptor tyrosine kinase inhibitor for the treatment of multiple myeloma, gastrointestinal stromal tumors and prostate cancer.
The drug had respectively, been entitled by FDA for the treatment of pancreatic cancer and ALS orphans disease in 2009 and 2015. On August 8, 2016, it has qualified as EMA orphan drug.
Masitinib is a novel kind of oral administrated tyrosine kinase inhibitors that could be targeted to immunizing important cellular mast cells and macrophages by inhibiting a certain amount of kinase. Based on its unique mechanism of action, masitinib can be developed for application in tumors, inflammatory diseases and certain central nervous system diseases.
In the oncology, due to its immunotherapy effect, Masitinib may affect the survival period of cancer patients (single administration or in combination with chemotherapy). By acting on mast cells and microglia, and further inhibiting the activation of the inflammatory process, Masitinib is effective against certain inflammatory, central nervous system disorders as well as symptoms associated with degeneration of these diseases.
Biological activity Masitinib (AB1010) is a novel Kit and PDGFRα/β inhibitor with IC50 of 200 nM and 540 nM/800 nM, respectively, however with weak inhibits on ABL and c-Fms. Phase 3.
In vitro Masitinib, at a concentration of ≤ 500 nM, it is a kind of ATP competitive inhibitors. Masitinib can also effectively inhibit the recombinant PDGFR and intracellular kinase Lyn, and FGFR3. However, Masitinib has a weak inhibitory effect on ABL and c-Fms. Masitinib acts on de-granulation, cytokine production, and bone marrow mast cell migration with the inhibitory effect being much stronger than imatinib. In Ba/F3 cells expressing human wild-type KIT, Masitinib can inhibit the SCF (stem cell factor)-induced cell proliferation with an IC50 being 150 nM and an IC50 value of being larger than 10 μM when inhibiting the IL-3 stimulated proliferation. In Ba/F3 cells expressing PDGFR-α, Masitinib is capable of inhibiting the PDGF-BB stimulated proliferation and PDGFR-alpha tyrosine phosphorylation with an IC50 of 300 nM. Masitinib acts on mast cell tumor cell lines and BMMC, and also inhibits the stimulated phosphorylation of human KIT tyrosine. Masitinib takes effect on the Ba/F3 cells to suppress the KIT-acquired functional mutations which include V559D mutations and Δ27 mutations with IC50s of 3 and 5 nM, respectively. Masitinib inhibits the cell proliferation of mast cell tumor cell lines including HMC-1α155 and FMA3 cells with the IC50 of 10 and 30 nM, respectively. Masitinib acts on two new ISS cell lines, inhibits cell growth and phosphorylation of PDGFR, indicating that Masitinib inhibits primary and metastatic ISS cell lines and is helpful in the clinical management of ISS.
In vivo 30 mg/kg Masitinib, when acting on the Ba/F3 transplanted tumor model expressing Δ27, is capable of inhibiting tumor growth and improving the survival time of the culture medium, and is non-toxic to both the heart and the gene. Daily oral administration of 12.5 mg/kg Masitinib improves all TTP (the grown tumor with the time). When the Masitinib and gemcitabine are used in combination to fight against the proliferation of the anti-gemcitabine cell lines during Mia Paca2 and Panc1 proliferation, they exhibit synergetic effects.
Feature Masitinib has a better safety than other tyrosine inhibitors.
Appearance Off-White to Pale Yellow Solid
Uses Masitinib is a novel tyrosine kinases inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, resectively.
Uses Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, weak inhibition to ABL and c-Fms. Phase 2/3
Uses Masitinib controlled-release implant for treating solid neoplasm.
Definition ChEBI: A member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N3-[4 (pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor.

Our service

1.100% reshipment policy is our business basic.100% reshipment immediately if your parcel stays Customs for 4 days and doesn’t get updated.
2.Total refund for 15 days of dissatisfaction with quality.
3.We can provide free samples.
4.We have a special packing ,It can be easily passed through the customs.It will be more safe.
5.Our company have a long term cooperate with DHL.EMS.Fedex and so on .It can be sent to your hand more quickly. Parcel photo should be offered within 12hours after receiving your steroid payment.
6.If you have a chance to come to China. I can show you our lab.
7.Our company has WU, MG, TT, and Bitcoin payment ways in advance.You can pay 95% for the peptides cost at first for order, the rest can offer us in your next order;

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
1 + 6 = ?

Maybe you like also

  • How to make order?

    Choose the items you wanna;
    Contact me via the email with your demand;
    Quote will be forwarded;
    Make the payment;
    Parcel arranged;
    Shippment arranged.
    Trace service will be provided.

  • Our Products

    Raw steroids powder

    SARMS

    Peptides

    Solvents

    APIS

    Filtering machine

    Tablets-press machine

    Vials, rubber, caps, cripmer

  • Shipment Servies

    EMS

    DHL

    Fedex

    TNT

    UPS

    EUB/ETK ect.

  • Contact Us

    Email:rawsteroidsale@gmail.com
    What's app:+8618676137192
    skype : +8618676137192
    Wedsite:http://www.powerfulsteroids.com/